Cyclosporine A affects serotonergic mechanisms in uremic rats

Polish Journal of Pharmacology

Volumn 48, Issue 3, 1996, Pages 351-354

  Krygicz, Dariusz ^a   Azzadin, Arsalan ^a   Pawlak, Robert ^a   Małyszko, Jacek S ^a   Pawlak, Dariusz ^a   Myśliwiec, Michał ^a   Buczko, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Blood platelets; Cyclosporine A; Serotonin; Uremic rats

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLOSPORIN A; KETANSERIN; SEROTONIN; SEROTONIN 2 ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL LEVEL; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; UREMIA;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PRESSURE; CYCLOSPORINE; KETANSERIN; KIDNEY FAILURE, CHRONIC; MALE; PLATELET AGGREGATION; RATS; RATS, WISTAR; SEROTONIN; UREMIA;

EID: 0029844439     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Azzadin A., Bialkowska A., Pawlak D., Chabielska E., Mazerska M., Myśliwiec M., Buczko W.: Serotonin is involved in some effects of erythropoietin. Thromb. Res., 1992, 65, 657-661.
2. Azzadin A., Małyszko J., Małyszko J. S., Buczko W., Myśliwiec M.: Correlation between serotonin concentration and blood pressure in kidney transplant recipients treated with cyclosporine. Nephron, 1996, 72, 336-337.
3. Benini A., Chiabrando C., Piccinelli A.: Increased excretion of thromboxane B2 and 2.3-dinor-TxB2 in cyclosporine A nephrotoxicity. Kidney Int., 1988, 34, 164.
4. Born G. V. R.: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 1962, 194, 927-929.
5. Curtis J. J.: Cyclosporine and posttransplant hypertension. J. Amer. Soc. Nephrol., 1992, 2, Suppl. 12, S243-S245.
6. Dos S. O.: Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane. Lipids, 1991, 26, 1320-1323.
7. Drummond A. H., Gordon J.: Rapid, sensitive microassay for platelet serotonin. Thromb. Diathes. Haemorrh., 1974, 31, 366-367.
8. Duarte J., Andrade J., Vargas F.: Vascular reactivity in chronic Goldblatt two kidney-one clip hypertensive rats. Experientia, 1990, 46, 868-869.
9. Eknoyan G., Brown C. H.: Biochemical abnormalities of platelets in renal failure. Amer. J. Nephrol., 1981, 1, 17-21.
10. Fetkovska N., Pletscher A., Ferracin F., Amstein R., Buhler F. R.: Impaired uptake of 5-hydroxytryptamine platelet in essential hypertension: clinical relevance. Cardiovasc. Drug. Ther., 1990, 1, 105-109.
11. Grace A. A., Barradas M. A., Mikhailidis D. P., Jeremy J. Y., Moorhead J. F., Sweny, Dandona P.: Cyclosporine A enhances platelet aggregation. Kidney Int., 1987, 32, 889-895.
12. Kon V., Sugiura R., Inagami T., Harvie R., Ichikawa L., Hoover R. L.: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int., 1990, 37, 1487-1491.
13. Koutouzow S., Cothenet-Vernoux L., Marche P., Dausse J. P.: Influence of alpha and beta-adrenoreceptors on thrombin-induced serotonin release in rat platelets. Thromb. Res., 1985, 40, 147-159.
14. Malyszko J., Mazerska M., Malyszko J. S., Pawlak K., Azzadin A., Myśliwiec M., Buczko W.: Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patients. Int. J. Clin. Lab. Res., 1993, 23, 42-44.
15. McNally P. G., Feehally J.: Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol. Dialysis Transplant., 1992, 7, 791-804.
16. Myśliwiec M., Azzadin A., Pawlak D., Szewczuk J., Buczko W.: Cyclosporin A induced increase in blood pressure correlated with increase in blood serotonin. Vth Congress of European Society for Organ Transplantation, Maastricht, The Netherlands, October 7-10. 1991.
17. 3 receptors. Naunyn-Schmied. Arch. Pharmacol., 1991, 344, 143-149.
18. Ueda D., Suzuki K., Małyszko J., Pietraszek M. H., Takada Y., Takada A., Kawabe K.: Fibrinolysis and serotonin under cyclosporine A treatment in kidney transplant recipients. Thromb. Res., 1994, 74, 97-102.
19. Van Zwieten P. A.: Pathophysiological relevance of serotonin. J. Cardiovasc. Pharmacol., 1987, 10 (Suppl. 3), s19-s25.
20. Vanrenterghem Y., Roels L., Lerut T., Gruwez J., Gresele P., Deckmyn H., Colucci M., Arnout J., Vermylen J.: Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet, 1985, i, 999-1002.